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Summary: PN 200-110 [4-(2,1,3-benzoxadiazol-4-)-1,4 -dihydro -2,6 -dimethyl -pyridine -3,5 -dicarboxylic acid methyl I-methylethyl ester], a new dihydropyridine de rivative, was investigated by recording isometric ten sion on spiral strips from human and canine arteries in tissue baths at 37°C. Responses to increasing concentra tions of CaCh were investigated in calcium-free depolar izing solution (60 mmollL KCI in equimolar replacement for NaC!, 50 mmollL TRIZMA buffer, pH 7.4). Compar ison of those concentrations that reduced the vasocon strictor response to 1.6 mmollL CaCh by 50% revealed the following order of potencies on both human and ca nine arteries: PN 200-110> nimodipine > nifedipine. Re sponses to 5-hydroxytryptamine (5-HT) and blood were investigated in Krebs-Henseleit solution (NaHC03 buffer). On canine arteries, PN 200-110 antagonized responses to 5-HT when used at 10 -30 pmollL; it was �70 times more Spasm of one or more cerebral arteries is fre quently observed within the first 10 days after rup ture of an intracranial aneurysm associated with se rious resultant neurological signs. In animal studies, biphasic changes of cerebral arterial spasm fol lowing subarachnoid bleeding were observed. Whereas 5-hydroxytryptamine (5-HT) may play an important role in the etiology of early spasm (1-2 h after the bleeding), the pathogenesis of late spasm is still uncertain. It has been shown that whereas phentolamine, phenoxybenzamine, and methyser gide can counteract (at least in part) the early spasm, potent on basilar than on mesenteric arteries, whereas both nifedipine and nimodipine were, respectively, � 10 and 6 times more potent on basilar than on mesenteric arteries. When canine basilar arteries were constricted by the addition of blood to the organ bath, each of the investigated dihydropyridine derivatives elicited concen tration-dependent relaxation, producing the following order of potencies: PN 200-110 > nifedipine = nimodi pine. On human anterior cerebral arteries, the blood-in duced contractions were counteracted in the following rank order: PN 200-110 = nimodipine > nifedipine. The results suggest that due to its potent calcium-blocking activity on cerebral arteries, PN 200-110 might be of value for the prevention and treatment of cerebrovascular spasms following subarachnoid hemorrhage. Key Words: Calcium influx blockers-Canine-Cerebral arteries Human-Vasospasm.
the late spasm could not be changed by these an tagonists (Nagai et aI., 1971 (Nagai et aI., , 1975 Allen et aI., 1974b,c; To da et aI., 1977) . Approximately 30 nat urally occurring substances, all of which are ob tainable from the tissues associated with a sub arachnoid hemorrhage, have been identified as ce rebral arterial constrictors (White, 1979) .
Animal experiments have demonstrated that smooth muscle relaxants, such as papaverine and isoxuprine, can relieve not only early but late spasms as well (Nagai et aI., 1971 (Nagai et aI., , 1975 . This implies that a selective antagonist of calcium channels should also be able to counteract cerebral vasoconstriction following a subarachnoid hemorrhage. Using iso lated human and canine arteries, we performed the following study to investigate and quantify the po tency of three calcium influx blockers and to com pare the antagonism of vasoconstrictor responses to both depolarization and blood on human and ca nine cerebral arteries.
Human anterior cerebral arteries were obtained during autopsy within 7-30 h (usually <20 h) after death. Canine basilar arteries and distal portions of the mesenteric ar tery were obtained from mongrel dogs of both sexes weighing between 15 and 30 kg, which were anaesthetized by rapid i. v. injection of pentobarbitone (50 mg/kg) and killed by i. v. injection of 100 ml air. The arteries were cut into helical strips (-10 mm in length and I mm in width), suspended in lO-ml organ baths containing the following Krebs-Henseleit solution (mmoIlL): NaCl, 118; KCl, 4.7; MgS04, 1. 2; CaCh, 1.2; NaHC03, 25; glucose, 11; and EDTA, 0 .03 at 37°C, and were gassed continu ously with 5% CO2 in oxygen. The tension of the strips was recorded isometrically with electromechanical trans ducers (Statham model UC 3) and a potentiometric re corder. At the beginning of the experiments, the strips were stretched to an initial tension of 500 mg and then allowed to equilibrate for 2 or 3 h in the bathing medium, which was changed every 15 min. The strips relaxed to a resting tension of about 100 -200 mg, which then re mained constant throughout the experiment. When the vasoconstrictor responses to increasing calcium chloride concentrations were investigated, the Krebs-Henseleit solution in the organ baths was replaced by a calcium free solution containing 60 mmollL potassium chloride in equimolar exchange for sodium chloride and 50 mmollL TRIZMA instead of NaHC03 buffer. The pH was ad justed to 7. 4. Concentration-response curves for CaCh or 5-HT were established by cumulative additions, each concentration being added when the maximum effect had been produced by the previous concentration. Antago nists were added 30 min before the first administration of the agonist. In each experiment, six strips of the same blood vessel were investigated at the same time, and at least one was used as a control preparation to correct for any sensitivity change not caused by the antagonist. To avoid foaming when vasospasm was induced by adding blood to the organ bath, a constant roller pump was used for stirring the bathing solution.
Drugs
The following pharmacological agents were used: ni fedipine, nimodipine (Bayer, Leverkusen, F.R. G. ), pa paverine hydrochloride, PN 200-110 (4-(2,1 ,3-benzox adiazol-4-yl)-I, 4-dihydro-2, 6-dimethyl-pyridine-3, 5-di carboxylic acid methyl I-methylethyl ester; Sandoz, Basel, Switzerland), 5-hydroxytryptamine creatinine sul fate (5-HT; Fluka, Buchs, Switzerland).
Whenever a calcium influx blocker was used, all light was excluded from the laboratory, except for a sodium vapor light (Osram), to prevent inactivation of those drugs. 5-HT and papaverine were prepared in the appropriate physiologic salt solution or distilled water. Nifedipine, nimodipine, and PN 200-110 were dissolved in ethanol. Further dilutions were made in distilled water; the highest ethanol level used was 0. 6% at the 0. 1 mmollL concen tration. All drugs were dissolved just before use. Human or canine blood (9 ml) was mixed thoroughly with I ml 3. 8% (wt/vol) sodium citrate and centrifuged at 1,000 g for 30 min at room temperature. The plasma was mixed with 1,000 U streptokinase, and both plasma and sediment were incubated for 48 h at 37°C. Thereafter, the sediment was resuspended in the plasma before use.
Statistical analysis of data was performed by analysis of variance (ANOVA) using a Student-Newman-Keuls test.
RESULTS

Human anterior cerebral arteries
Blockade of depolarization-induced contractions.
When the normal Krebs-Henseleit solution was re placed by a calcium-free TRIZMA buffer containing 60 mmol/L KCI, the addition of increasing concen trations of CaCh produced concentration-depen dent increases in tone of the vascular strips. Pre treatment of the preparations with PN 200-110, ni fedipine, or nimodipine ( Fig. 1 ) displaced the calcium chloride curve to the right and at the same time diminished the maximal responses to CaCI 2 . Al though the displacement of the calcium chloride curves suggested noncompetitive antagonism, for comparison purposes IC5 0 values (those concentra tions of the antagonists which reduce the maximum response to the agonist by 50%) were calculated at the 1.6 mmol/L CaCh effect levels. The estimated IC5 0 values, 33 pmollL for PN 200-110, 0.3 nmollL for nimodipine, and 2.2 nmollL for nifedipine, in dicate that during depolarization of human anterior cerebral arteries, the antagonism of calcium effects by PN 200-110 was � 10 and 70 times stronger than those produced by nimodipine and nifedipine, re spectively ( Table 1) .
Inhibition of blood-induced vasospasm. The ad dition of 500 IJ-I streptokinase-incubated human blood to the organ bath produced a long-lasting in crease in tone of human anterior cerebral arteries. This contraction, which leveled off after �60 min, could be reversed in a concentration-dependent way by the calcium influx blockers as well as by the phosphodiesterase inhibitor papaverine. On human anterior cerebral arteries, both PN 200-110 and ni modipine proved to be equally potent in reversing the blood-induced vasospasm. Nifedipine was about six times less potent (p < 0.01) than the former, whereas papaverine caused relaxation only when used at concentrations � 1,000 times higher than that of calcium influx blockers (Fig. 2 , Table 1 ).
Canine basilar and mesenteric arteries
After replacement of the normal Krebs-Henseleit solution by a calcium-free TRIZMA buffer con taining 60 mmol/L KCI, again the addition of in creasing concentrations of CaCh produced concen tration-dependent increases in tone of both canine basilar and mesenteric arteries. PN 200-110, used at concentrations of 0.1 pmol/L to 1 nmollL, shifted the concentration-response curve for CaCh on ca nine basilar arteries to the right and at the same time diminished the maximal effects ( Fig. 3, top) . On canine mesenteric arteries, PN 200-11 0 also shifted the concentration-response curve for CaCh to the right, but the curve became progressively steeper when the calcium concentrations exceeded 6.4 mmol/L (Fig. 3, bottom) . For purposes of com parison, IC 50 values were calculated for the vaso constrictor response to 1.6 mmol/L CaCho The neg ative logarithms of these IC 50 values are summa rized in Ta ble 1. Comparison of these c oncentrations revealed that PN 200-110 was equally potent in an tagonizing calcium-induced contractions in both ca nine basilar (lC 50 = 3.1 pmol/L) and mesenteric (IC 50 = 5.4 pmol/L) arteries.
As observed with PN 200-110, nifedipine proved to be equally potent in antagonizing responses to CaCh on both canine arteries. The calculated IC 50 values of 2.3 and 2.0 nmollL on canine basilar and mesenteric arteries, respectively, were statistically not significantly different ( Fig. 4 , Ta ble I). Com-pared to PN 200-110, however, �400 and 700 times higher concentrations of nifedipine were neces sary to produce the same inhibitory effect. On ca nine mesenteric arteries, again the presence of ni fedipine produced progressively steeper curves for CaCl 2 above 6.4 mmol/L (Fig. 4, bottom) .
Nimodipine antagonized responses to CaCh on canine basilar arteries with an IC 50 of 0.3 nmollL, thus being approximately eight times more potent than nifedipine (Fig. 5, top) . When tested on canine mesenteric arteries, again the concentration-re sponse curve became progressively steeper in the presence of the antagonist (Fig. 5, bottom) , but based on the IC 50 values calculated at the 1.6 mmoll L CaCl 2 effect level, nimodipine, like the former antagonists, was equally potent in antagonizing re sponses to CaCl 2 on both canine arteries.
Comparison of the IC 50 values estimated on ca nine basilar arteries with those calculated on human anterior cerebral arteries revealed that both nifedi- , The difference between human anterior cerebral and canine basilar arteries is significant (p < 0.01). b The difference between the IC,a value against blood and that against CaCl, on the same vessel is significant (p < 0.01). < The difference between the IC" value against 5-HT and that against CaCI, on the same vessel is significant (p < 0.01). d The difference between canine basilar and mesenteric arteries is significant (p < 0.01). pine and nimodipine were equally potent on the ce rebral arteries from both species, whereas PN 200-110 was about 10 times more potent in antagonizing depolarization-induced vasoconstrictor responses on canine than on human cerebral arteries. Inhibition of 5-HT-induced contractions. When tested against 5-HT, PN 200-110 proved to be sig nificantly more potent in counteracting the vaso constrictor activity of this amine on basilar than on mesenteric arteries. Although on basilar arteries a 50% reduction of the maximal 5-HT effect could be obtained with 56 pmolJL, a concentration of PN 200-110 nearly 70 times higher (3.7 nmollL; p < 0.01) was necessary to achieve the same reduction of 5-HT effects on mesenteric arteries (Fig. 6) .
Nifedipine reduced the maximal 5-HT effect on canine basilar arteries by 50% when used at a con centration of 3.6 nmollL. On mesenteric arteries, however, maximal responses to 5-HT could be di minished by only 45%. This inhibition was obtained with 100 nmol/L nifedipine. Increasing the concen tration of the antagonist did not cause further re duction of the vasoconstrictor response of mesen teric arteries to 5-HT (Fig. 7) . Based on those con centrations, which caused a 25% inhibition on both vascular preparations, nifedipine was at least 10 times more potent on canine basilar than on canine mesenteric arteries.
Nimodipine antagonized responses to 5-HT of basilar arteries (ICso = 3.8 nmollL) at concentra tions six times lower than those of mesenteric ar teries (ICs o = 21 nmoIlL), a statistically significant difference (p < 0.01) (Fig. 8) .
Inhibition of blood-induced vasospasm. As ob served with human anterior cerebral arteries, the addition of 500 fLl streptokinase-incubated canine blood to the organ bath evoked a long-lasting in crease in tone of canine basilar arteries. On this arterial preparation, PN 200-11 0 eliminated 50% of the blood-induced constriction when used at 2.2 nmollL, whereas 7.1 and 7.9 nmol/L were neces sary to produce the same inhibition with nifedipine and nimodipine, respectively ( Fig. 9 , Ta ble 1). As observed with human arteries, papaverine was ac tive only when used at concentrations 1,000 times higher than those of the dihydropyridine deriva tives.
DISCUSSION
The existence of two different populations of cal cium channels (i.e., "potential-sensitive" and "re ceptor-operated") has been postulated, and it is recognized that depolarization-induced contrac tions of smooth muscle are produced by activation of potential-sensitive channels, which are suscep tible to organic calcium influx blockers (Van Breemen, 1977; Bolton, 1979) . In the present study, isolated arteries of comparable size (namely, human anterior cerebral and canine basilar and mesenteric) were employed. In all vessels, the depolarization induced contractions could be antagonized by each of the investigated calcium influx blockers. How ever, although on cerebral arteries from both hu mans and dogs the shift of the concentration-re sponse curve for calcium chloride was roughly com parable to that described for noncompetitive antagonism, on canine mesenteric arteries the cal cium chloride curve became progressively steeper when the calcium concentration exceeded 6.4 mmo lJ L. This phenomenon might be mediated by the re lease of calcium from intracellular stores such as mitochondria, sarcoplasmic reticulum, or inner sur face of cell membrane, triggered by high calcium concentrations (Bolton, 1979) . For purposes of comparison, therefore, ICso values for inhibition of depolarization-induced contractions were calcu lated at the 1.6 mmollL CaClz effect level, which is within the range of extracellular calcium concentra tion under physiologic conditions. Comparison of these ICso values revealed that each of the studied dihydropyridines was equipotent in antagonizing depolarization-induced vasoconstriction in both ca nine cerebral and peripheral arteries, suggesting that the binding sites for dihydropyridine derivatives at vascular potential-sensitive channels within the same species are identical. On the other hand, although both nifedipine and nimodipine produced nearly identical IC 50 values against CaCh in cerebral ar teries from humans and dogs, PN 200-110 was about 10 times less potent in human than in canine cere bral arteries, suggesting that there may exist spe cies-dependent structural differences between the binding sites for dihydropyridine derivatives at the potential-sensitive channels of arteries of even the same origin.
As far as receptor-operated channels are con cerned, there exist marked differences not only be tween species but also from vessel to vessel (Hay ashi Cohen and Allen, 1981; Shimizu et aI., 1980; Towart, 1981; Towart et aI., 1982) . Both cerebral and peripheral canine arterial preparations were constricted by 5-HT within the same concen tration ranges, and in the presence of calcium influx blockers the maximal responses to 5-HT were di minished on both types of blood vessels. However, comparison of concentrations of equal effectiveness revealed marked regional differences in the activity of the investigated calcium influx blockers. As in dicated by the calculated concentrations for 50% inhibition of the vasoconstrictor effect of 5-HT (Table  1) , PN 200-110 was not only the most potent antag onist on canine basilar arteries but also the most selective calcium influx blocker (�70 times more potent on basilar than on mesenteric arteries). The selectivity for basilar arteries of both nimodipine and nifedipine was only approximately 6 and 10 times higher than that for the peripheral artery. One interesting finding was the observation that on mes enteric arteries, nifedipine diminished the maximal response to 5-HT by only 45%, suggesting the in volvement of more than one mechanism of action. These results are in line with reports demonstrating a selective action of nifedipine on cerebral arteries as compared to peripheral arteries from both hu mans (Brandt et aI., 1981) and dogs (Allen and Bang hart, 1979; Cohen and Allen, 1981) . It was postu lated that the higher susceptibility of basilar arteries to calcium influx blockers was due to the fact that this artery uses primarily extracellular calcium as the source of activator calcium for contraction, whereas in the peripheral artery an intracellular bound pool of calcium might be the main source of activator calcium (Allen et aI., 1976a; Allen and Banghart, 1979; Cohen and Allen, 1981) .
The suggestion that subarachnoid hemorrhage is the cause for the late prolonged vasospasm of one or more great cerebral arteries was supported by the observation that human cerebrospinal fluid (CSF) from patients 2-10 days following a sub arachnoid hemorrhage provoked contraction of human and canine basilar arteries in vitro, whereas normal CSF had no effect (Allen et aI., 1974a (Allen et aI., ,b, 1976b Starling et aI., 1975; Boullin and Mohan, 1977; Blaso and Boullin, 1978; Boullin et aI., 1981) . Therefore, a second series of experiments was car- ried out to investigate the antagonism of blood-in duced vasospasm on human and canine cerebral ar teries, with streptokinase-incubated blood from hu mans and dogs. In this experimental model on human anterior cerebral arteries, both PN 200-110 and nimodipine proved to be � 10 times more potent than nifedipine (p < 0.01), which in addition has been shown to abolish plasma-induced contractions of human pial arteries when used at concentrations of 300 and 600 nmoliL (Edvinsson et aI., 1979) .
The effective treatment of cerebral spasm re quires a drug that selectively relaxes cerebral ar teries in spasm without changing the tone of pe ripheral arteries. Allen and Bahr (1979) demon strated that sublingually administered nifedipine (1 mg/kg) could both prevent and reverse the acute (early) and chronic (late) phase of cerebral arterial spasm in dogs caused by subarachnoid injection of blood. As pointed out by those investigators, sig nificant hypotension has rarely been a side effect in the clinical trials with nifedipine, supporting a rel atively selective effect of nifedipine on cerebral ar teries as compared to peripheral arteries, such as femoral (Allen and Banghart, 1979) or mesenteric (present study) arteries from dogs.
In conclusion, the present results, demonstrating potent blocking activity of three dihydropyridine derivatives against depolarization, 5-HT, and blood induced spasm on canine basilar arteries (in addi- tion to the potent antagonism of depolarization and blood-induced spasm on human anterior cerebral arteries), justify investigations of calcium antago nists such as PN 200-11 0 as a treatment of late pro longed vasospasm following subarachnoid hemor rhage.
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